laevo-ornithine laevo-aspartate, 3230-94-2

Articles:

PubMed:	[The use of remaxol in combined intensive therapy of acute mushroom poisoning].
PubMed:	[Meta-analysis of the efficacy and safety of telaprevir combined with peginterferon alfa plus ribavirin in patients with chronic hepatitis C].
PubMed:	[Ornithine aspartate and naloxone combined therapy for hepatic encephalopathy affects cognitive function, prognosis, and neuropeptide levels].
PubMed:	[Hepatic dysfunction correction in patients with obturation jaundice].
PubMed:	Modulation of neural activation following treatment of hepatic encephalopathy.
PubMed:	l-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: a meta-analysis of randomized controlled trials.
PubMed:	Sequence position and side chain length dependence of charge pair interactions in collagen triple helices.
PubMed:	[Hepatic encephalopathy and liver transplantation].
PubMed:	Critical analysis of studies evaluating the efficacy of infusion of L-ornithine L-aspartate in clinical hepatic encephalopathy in patients with liver failure.
PubMed:	Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy.
PubMed:	[Optimization of treatment of patients with chronic cardiac insufficiency of the ischemic genesis and hobnail liver].
PubMed:	Efficacy of L-ornithine-L-aspartate as an adjuvant therapy in cirrhotic patients with hepatic encephalopathy.
PubMed:	A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
PubMed:	The effect of L-ornithine L-aspartate and branch chain amino acids on encephalopathy and nutritional status in liver cirrhosis with malnutrition.
PubMed:	Hepatic encephalopathy.
PubMed:	[Study on L-Ornithine-L-Aspartate in the treatment of acute-on-chronic liver failure].
PubMed:	Oral L-ornithine-L-aspartate improves health-related quality of life in cirrhotic patients with hepatic encephalopathy: an open-label, prospective, multicentre observational study.
PubMed:	Effect of l-ornithine l-aspartate against thioacetamide-induced hepatic damage in rats.
PubMed:	Normal protein diet and L-ornithine-L-aspartate for hepatic encephalopathy.
PubMed:	Interorgan ammonia metabolism in liver failure: the basis of current and future therapies.
PubMed:	[Physiological functions of L-ornithine and L-aspartate in the body and the efficacy of administration of L-ornithine-L-aspartate in conditions of relative deficiency].
PubMed:	[Reduction of hospital stay with the use of L-ornithine L-aspartate (LOLA) in patients with hepatic encephalopathy].
PubMed:	[Hepatic encephalopathy. L-ornithine-L-aspartate stimulate detoxification capacity of the liver].
PubMed:	Pharmacotherapy for hepatic encephalopathy.
PubMed:	A double-blind, randomized, placebo-controlled trial of intravenous L-ornithine-L-aspartate on postural control in patients with cirrhosis.
PubMed:	Metal toxicity, liver disease and neurodegeneration.
PubMed:	Minimal hepatic encephalopathy.
PubMed:	A critical analysis of studies assessing L-ornithine-L-aspartate (LOLA) in hepatic encephalopathy treatment.
PubMed:	Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study.
PubMed:	Treatment of hyperammonemia in liver failure: a tale of two enzymes.
PubMed:	L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy.
PubMed:	L-Ornithine-l-aspartate in the management of hepatic encephalopathy: a meta-analysis.
PubMed:	[Efficiency of prevention and treatment of veno-occlusive disease of the liver after allogeneic stem cell transplantation].
PubMed:	[New approach to diagnostics and correction of portohepatic hemodynamics in patients with chronic liver diseases].
PubMed:	[Fulminate liver failure in a 39-year-old female patient with leukocytosis, unclear fever, and arthralgic pain].
PubMed:	Hepatic encephalopathy: pathophysiology and advances in therapy.
PubMed:	The treatment of hepatic encephalopathy.
PubMed:	Hepatic encephalopathy following transjugular intrahepatic portosystemic shunt (TIPS): management with L-ornithine-L-aspartate and stent reduction.
PubMed:	Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study.
PubMed:	Hepatic encephalopathy: a review of its pathophysiology and treatment.
PubMed:	Effect of ascorbic acid, alpha-tocopherol, lecithin and L-ornithine-L-aspartate on ethanol induced hypoproteinemia and hyperlipidemia in rats.
PubMed:	Pharmacokinetics and bioavailability study of L-ornithine-L-aspartate in healthy volunteers--a comparative study of two oral formulations.
PubMed:	Validated method for L-ornithine-L-aspartate analysis in human plasma by capillary electrophoresis.
PubMed:	[Therapeutic effect of L-ornithine-L-aspartate on liver cirrhosis complicated by hepatic encephalopathy].
PubMed:	Recovery from parkinson syndrome and prolonged visually evoked potentials in hepatic encephalopathy.
PubMed:	[Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
PubMed:	[New concepts in the physiopathology of hepatic encephalopathy and therapeutic prospects].
PubMed:	[Cirrhotic liver gives up in breaking up of ammonia. Poison for the brain].
PubMed:	Brain edema in acute liver failure.
PubMed:	[Because hepatic encephalopathy is a frequent contributing factor. Patients with liver cirrhosis are poorer drivers].
PubMed:	[Hepatic encephalopathy--therapy].
PubMed:	Hepatic encephalopathy: nomenclature, pathogenesis and treatment.
PubMed:	Clinical efficacy of L-ornithine-L-aspartate in the management of hepatic encephalopathy.
PubMed:	Liver transplantation improves hepatic myelopathy: evidence by three cases.
PubMed:	Management of hepatic encephalopathy.
PubMed:	[Researching progress of prevention and treatment of hepatic failure encephalopathy].
PubMed:	[The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
PubMed:	Proton MR spectroscopy of neurometabolites in hepatic encephalopathy during L-ornithine-L-aspartate treatment--results of a pilot study.
PubMed:	[Chronic liver diseases. The nihilism has gone].
PubMed:	[In liver cirrhosis, not every "ammonia lowering drug" improves neuropsychiatric deficit].
PubMed:	Effect of L-ornithine-L-aspartate on patients with and without TIPS undergoing glutamine challenge: a double blind, placebo controlled trial.
PubMed:	[Chronic liver diseases. Hepatic encephalopathy too frequently overlooked?].
PubMed:	Complications of cirrhosis III. Hepatic encephalopathy.
PubMed:	L-ornithine aspartate - a rationale for its use in combination with chemotherapy, radiation, and hyperthermia in oncology.
PubMed:	L-ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure.
PubMed:	L-ornithine-L-aspartate in experimental portal-systemic encephalopathy: therapeutic efficacy and mechanism of action.
PubMed:	Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study.
PubMed:	Treatment of cirrhotic rats with L-ornithine-L-aspartate enhances urea synthesis and lowers serum ammonia levels.
PubMed:	Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
PubMed:	L-ornithine vs. L-ornithine-L-aspartate as a treatment for hyperammonemia-induced encephalopathy in rats.
PubMed:	Review article: pathogenesis and treatment of chronic hepatic encephalopathy.
PubMed:	Contrasting effects of thioacetamide-induced liver damage on the brain uptake indices of ornithine, arginine and lysine: modulation by treatment with ornithine aspartate.
PubMed:	[Hepatic minimal encephalopathy. The most frequently overlooked, clinically occult "metabolic syndrome" on the cirrhosis patient].
PubMed:	[The treatment of hepatic encephalopathy with Hepa-Mertz].
PubMed:	[Ornithine aspartate in hepatic encephalopathy: an established new therapeutic approach. Overview and results of current randomized studies].
PubMed:	Effects of ornithine aspartate on plasma ammonia and plasma amino acids in patients with cirrhosis. A double-blind, randomized study using a four-fold crossover design.
PubMed:	Long-term effectiveness of high-dosed ornithine-aspartate on urea synthesis rate and portal hypertension in human liver cirrhosis.
PubMed:	[Amino acids prevent hepatic encephalopathy. Ornithine-aspartate in hyperammonemia--results of a study].
PubMed:	X-ray studies on crystalline complexes involving amino acids and peptides. IX. Crystal structure of L-ornithine L-aspartate hemihydrate.
PubMed:	[Influence of ornithine aspartate on the experimentally induced hyperammoniemia. Clinico-experimental study].
PubMed:	Intravenous loading with arginine-hydrochloride and ornithine-aspartate in siblings of two families, presenting a familial neurological syndrome associated with cystinuria.
PubMed:	[Clinical experiences in liver diseases (specially in patients with fatty liver due to alcoholism and food poisoning) under monotherapy with ornithine aspartate].
PubMed:	[Influence of ornithine-aspartate on the increased GOT activity in bovine serum].
PubMed:	[Further clinical experiences with ornithine aspartate in liver diseases].
PubMed:	[Effect of ornithine-aspartate on fecal excretion of mevalonate metabolites and the reticuloendothelial system].
PubMed:	[Our clinical experience with ornithine aspartate].
PubMed:	Protection by ornithine-aspartate of the effects of physical exercise.
PubMed:	[Radiophysical studies: irradiation of ornithine aspartate in the Siemens training reactor SUR 100].
PubMed:	[Personal experiences in the treatment of internal diseases with ornithine aspartate].
PubMed:	[Experiences with ornithine-aspartate in liver diseases].
PubMed:	[On the therapy of liver diseases with ornithine aspartate].
PubMed:	[Intravenous administration of ornithine aspartate to patients with hepatic diseases].
PubMed:	Effect of ornithine-aspartate mixture on 15N-ammonia incorporation into urea in intact mice.
PubMed:	[Study of the treatment of liver damage due to several causes in tuberculosis, using ornithine-aspartate].